| SCHRODER ISF QEP EMERGING MARKETS CORE C ACC GBP | RVI EMERGENTES VALOR | 19,31% | 77,77% | 40,08% | · |
| CHALLENGE HEALTHCARE OPPORTUNITIES S-A | RVI SALUD | 19,30% | 22,43% | 13,04% | 45,74% |
| INVESCO S&P WORLD INFORMATION TECHNOLOGY ESG UCITS ETF ACC | RVI TECNOLOGÍA | 19,30% | 112,65% | · | · |
| JPM GLOBAL HEALTHCARE A (ACC) EUR | RVI SALUD | 19,30% | 30,38% | 19,45% | 123,44% |
| JPM GLOBAL HEALTHCARE A (DIST) EUR | RVI SALUD | 19,30% | 30,35% | 19,39% | 122,46% |
| M&G (LUX) EUROPEAN STRATEGIC VALUE FUND EUR JI ACC | RVI EUROPA VALOR | 19,30% | 87,53% | 108,88% | · |
| M&G (LUX) GLOBAL EMERGING MARKETS FUND USD LI ACC | RVI EMERGENTES | 19,30% | · | · | · |
| NOMURA FUNDS IRELAND - AMERICAN CENTURY EMERGING MARKETS EQUITY FUND A USD | RVI EMERGENTES | 19,30% | 77,86% | 23,15% | · |
| JPM ASIA GROWTH I (ACC) EUR | RVI ASIA EX-JAPÓN CRECIMIENTO | 19,29% | 66,26% | 23,28% | · |
| PRIVILEDGE - JPMORGAN EUROZONE EQUITY (GBP) M CAP SYST. HDG | RV EURO | 19,29% | 89,75% | 80,43% | · |
